Alnylam Pharma(ALNY)
$156.65-3.20 (-2.00%)
ALNY
Alnylam Pharma ownership
$156.65
At close:-3.20 (-2.00%)
Want to see ALNY full AI Analyst Report?
Alnylam Pharma (ALNY) Ownership - Who Owns Alnylam Pharma?
1,656 Followers
Alnylam Pharma (ALNY) Ownership Overview
- 0.25% Insiders
- 44.46% Mutual Funds
- 27.29% Other Institutional Investors
- 25.36% ETFs
- 2.64% Public Companies and Individual Investors
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail, and individual investors. Approximately 97.11% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 2.64% is owned by Public Companies and Individual Investors.
The ownership structure of Alnylam Pharma (ALNY) stock is a mix of institutional, retail, and individual investors. Approximately 97.11% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 2.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 11, 2026 | Charles Elliott Sigal | $243,600 | |
| Nov 11, 2026 | Amy Schulman | $299,526 | |
| Apr 06, 2026 | Melissa Mclaughlin | $519,014 | |
| Mar 05, 2026 | Pushkal Garg | $745,984 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Dodge & Cox | $588,631,955 | |
| Jun 30, 2026 | Bridgewater Associates, Lp | $29,977,772 | |
| Jun 30, 2026 | Fisher Asset Management Llc | $1,882,040 | |
| Jun 30, 2026 | Driehaus Capital Management Llc | $12,867,828 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 12,683,368 | Institution | 9.47% | 1,986,849,597 |
| Vanguard Index Funds | 11,465,798 | Institution | 8.56% | 1,796,117,257 |
| BlackRock, Inc. | 10,907,675 | Institution | 8.14% | 1,708,687,289 |
| Growth Fund Of America | 8,960,487 | Institution | 6.69% | 1,403,660,289 |
| Ishares | 6,744,241 | Institution | 5.04% | 1,056,485,353 |
| Amcap Fund | 4,526,680 | Institution | 3.38% | 709,104,422 |
| Invesco | 4,401,324 | Institution | 3.29% | 689,467,405 |
| Amundi | 2,991,083 | Institution | 2.23% | 468,553,152 |
| Fidelity Securities Fund | 2,942,338 | Institution | 2.20% | 460,917,248 |
| Vanguard Specialized Funds | 2,136,580 | Institution | 1.60% | 334,695,257 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 11,465,798 | Institution | 8.56% | 1,796,117,257 |
| Growth Fund Of America | 8,960,487 | Institution | 6.69% | 1,403,660,289 |
| Amcap Fund | 4,526,680 | Institution | 3.38% | 709,104,422 |
| Fidelity Securities Fund | 2,942,338 | Institution | 2.20% | 460,917,248 |
| Vanguard Specialized Funds | 2,136,580 | Institution | 1.60% | 334,695,257 |
| T. Rowe Price Capital Appreciation Fund, Inc. | 2,034,761 | Institution | 1.52% | 318,745,311 |
| Investment Co Of America | 1,612,942 | Institution | 1.20% | 252,667,364 |
| Dodge & Cox Funds | 1,448,441 | Institution | 1.08% | 226,898,283 |
| Fidelity Mt. Vernon Street Trust | 1,403,578 | Institution | 1.05% | 219,870,494 |
| Fidelity Concord Street Trust | 1,377,518 | Institution | 1.03% | 215,788,195 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 4,251,828 | Institution | 3.17% | 1,049,096,041 |
| Vanguard Mid-Cap ETF, VO ETF | 2,865,302 | Institution | 2.14% | 706,984,615 |
| Invesco QQQ Trust, QQQ ETF | 2,843,208 | Institution | 2.12% | 454,486,799 |
| Vanguard Growth ETF, VUG ETF | 1,761,551 | Institution | 1.32% | 434,645,094 |
| Vanguard Extended Market ETF, VXF ETF | 1,506,822 | Institution | 1.13% | 371,793,260 |
| Vanguard Mid-Cap Growth ETF, VOT ETF | 1,050,507 | Institution | 0.78% | 259,202,097 |
| iShares Biotechnology ETF, IBB ETF | 1,027,410 | Institution | 0.77% | 160,943,777 |
| Capital Group Growth ETF, CGGR ETF | 839,967 | Institution | 0.63% | 134,268,725 |
| iShares Russell Mid-Cap Growth ETF, IWP ETF | 753,510 | Institution | 0.56% | 118,037,342 |
| Invesco NASDAQ 100 ETF, QQQM ETF | 654,524 | Institution | 0.49% | 104,625,661 |
FAQ
Who Owns Alnylam Pharma (ALNY)?
According to the latest TipRanks data, approximately 97.11% of the company's stock is held by institutional investors, 0.25% is held by insiders, and 2.64% is held by public companies and individual investors.
What percentage of Alnylam Pharma (ALNY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 97.11% of Alnylam Pharma (ALNY) stock is held by institutional investors: 44.46% by mutual funds, 25.36% by ETFs and 27.29% by other institutional investors.
What percentage of Alnylam Pharma (ALNY) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.64% of Alnylam Pharma (ALNY) stock is held by public companies and individual investors.
Who owns the most shares of Alnylam Pharma (ALNY)?
Vanguard owns the most shares of Alnylam Pharma (ALNY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
